Monday, August 9, 2021

New Health Care Outreach Toolkit Available

Having trouble viewing this email? View it as a Web page.

From Our Partners

Bookmark and Share

New Health Care Outreach Toolkit Available

Communicating clearly and effectively about a community-based organization's capabilities removes one of the biggest barriers to health care contracting for aging and disability community-based organizations (CBOs), allowing for successful cross-sector partnerships and healthier communities. A new toolkit guides aging and disability CBOs seeking partnerships and conducting outreach with potential health care partners.

The Aging and Disability Business Institute has released the Health Care Outreach Toolkit, developed in partnership with Partners in Care Foundation and the Business Institute's Health Care Outreach working group. It provides aging and disability CBOs with guidance on conducting outreach to potential health care partners and crafting effective messaging.

The toolkit includes customizable messages and potential outreach targets for common types of health care partners—Medicare Advantage plans, Medicaid health plans, hospitals, accountable care organizations, and more. Check out the toolkit and get started on health care outreach efforts today.


Want more news from the Aging and Disability Business Institute? Stay up-to-date on the latest resources and materials by subscribing to their biweekly newsletter.

Administered by the National Association of Area Agencies on Aging (n4a), the Business Institute is supported by funding from The John A. Hartford Foundation, the Administration for Community Living and The SCAN Foundation.


Back to top

FacebookTwitterYoutube

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: Administration for Community Living
·330 C Street SW  · Washington, D.C. 20001
GovDelivery logo

No comments:

Post a Comment

Most important medical advance in 100 years

Artificial Intelligence is being harnessed to create breakthrough drugs no one has ever seen before. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ...